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Abstract
Purpose Brassica are an important food source worldwide and are characterised by the presence of compounds called glu-
cosinolates. Studies indicate that the glucosinolate derived bioactive metabolite sulphoraphane can elicit chemoprotective 
benefits on human cells. Glucosinolates can be metabolised in vivo by members of the human gut microbiome, although the 
prevalence of this activity is unclear. Brassica and Allium plants also contain S-methylcysteine sulphoxide (SMCSO), that 
may provide additional health benefits but its metabolism by gut bacteria is not fully understood.
Methods We examined the effects of a broccoli leachate (BL) on the composition and function of human faecal microbiomes 
of five different participants under in vitro conditions. Bacterial isolates from these communities were then tested for their 
ability to metabolise glucosinolates and SMCSO.
Results Microbial communities cultured in vitro in BL media were observed to have enhanced growth of lactic acid bacteria, 
such as lactobacilli, with a corresponding increase in the levels of lactate and short-chain fatty acids. Members of Escherichia 
isolated from these faecal communities were found to bioconvert glucosinolates and SMCSO to their reduced analogues.
Conclusion This study uses a broccoli leachate to investigate the bacterial-mediated bioconversion of glucosinolates and 
SMCSO, which may lead to further products with additional health benefits to the host. We believe that this is the first study 
that shows the reduction of the dietary compound S-methylcysteine sulphoxide by bacteria isolated from human faeces.
Keywords Broccoli · Glucosinolates · S-methylcysteine sulphoxide · Human gut microbiome · Lactobacilli · Short chain 
fatty acids
Introduction
The structure of the human gut microbiome is influenced by 
multiple factors, such as mode of birth [1], age [2], host gen-
otype [3], antibiotic treatment [4], environmental factors [5] 
and diet [6, 7]. As such, a large variation in the gut microbi-
ome has been observed between individuals [8, 9] and diet 
is considered to be one of the most influential environmental 
factors determining the composition of the human gut micro-
biome [10]. Studies indicate that a long-term diet rich in 
fibre correlates with an increased abundance of Prevotella, 
whilst a long-term diet containing high levels of protein and 
fat is associated with higher levels of Bacteroides [7, 10]. 
Short-term dietary interventions can result in rapid changes 
to the composition of the gut microbiome, but the commu-
nity tends to revert to the original composition within days 
after the intervention [6, 10]. This illustrates the elasticity 
and the range of functional capabilities within the micro-
biome; as the nutrient profile of the intestinal environment 
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changes, the composition of the bacterial community alters 
to maximise nutrient utilisation. Lactic acid bacteria (LAB) 
form part of the gut microbiome and are considered to be 
beneficial to the host. Although these bacteria have limited 
biosynthetic capabilities, they are efficient metabolisers of 
carbohydrates [11]. The major fermentation product is lac-
tic acid, which can be further metabolised to produce other 
SCFAs [12]. Although SCFAs are bacterial waste products, 
these compounds have been shown to have beneficial prop-
erties for human health [13]. Many Firmicutes, including 
LAB, have evolved to be tolerant of the acidic microenvi-
ronments that are generated at the sites of colonic substrate 
fermentation [14]. Acid tolerance can give these bacteria a 
competitive advantage over others, such as Bacteroides and 
strains of Escherichia coli, whose growth has been shown 
to be inhibited at a physiologically relevant pH of 5.5 [14].
Links between the diet, gut microbiome and health-
promoting effects have led to an increased interest in iden-
tification of functional foods that promote the growth of 
beneficial bacteria. Brassica vegetables, such as broccoli, 
are considered nutritious and are a rich source of fibres, 
vitamins, minerals, carotenoids and phenolic compounds 
[15]. These plants are characterised by the presence of phy-
tochemicals called glucosinolates, which have a role in plant 
defence through hydrolysis by the plant myrosinase enzyme. 
However, cooking these vegetables can inactivate the plant 
myrosinase. Therefore, we rely on the myrosinase-like activ-
ity of the gut microbiome to hydrolyse glucosinolates and 
form bioactive breakdown products, such as isothiocyanates 
(ITCs). Research has shown that single strains of human gut 
bacteria from a range of phyla have the ability to hydrolyse 
glucosinolates [16–19], that bacterial glucosinolate metabo-
lism occurs in vivo with a potential role for enterohepatic 
recycling [20, 21] and that there are inter-individual differ-
ences in glucosinolate metabolism, as evidenced by varia-
tion in urinary ITC excretion [22]. Studies have determined 
that human gut bacteria are able to convert glucosinolates, 
such as glucoraphanin and glucoiberin, via the reduction 
of a sulphoxide group [23–25]. It has been postulated 
that the reduction of glucosinolates may be a mechanism 
employed by some bacteria to overcome steric hindrance, 
caused by the presence of the sulphoxide groups rendering 
the β-thioglucosidic bonds inaccessible to bacterial myrosi-
nase-like enzymes [23]. It was shown that a strain of E. coli 
did not exhibit the ability to hydrolyse glucosinolates until 
after it had converted them to their reduced analogues [23]. 
This indicates that there may be multiple mechanisms by 
which the human gut microbiome can hydrolyse glucosi-
nolates. S-methylcysteine sulphoxide (SMCSO) is found in 
Brassica and Allium and is thought to function as a phyto-
alexin, providing protection against microbial pathogens and 
herbivores through its degradation by cysteine sulphoxide 
lyases [26, 27]. Bacterial cysteine β-lyase activity has been 
detected within the human gut microbiome and has been 
attributed to a diverse range of bacteria, including E. coli 
[28, 29]. The bacterial cysteine lyase has broad substrate 
specificity and is able to cleave the C–S bonds of a range of 
S-alkyl-cysteine molecules, in a manner similar to the plant 
cysteine lyases [26]. Research into the beneficial effects of 
SMCSO and its metabolic products have indicated that this 
dietary compound may exhibit protective effects against can-
cer [30–32], diabetes [33] and cardiovascular disease [34, 
35].
In the current study, we examined the effects of a broc-
coli leachate on the composition and function of five human 
faecal microbiomes and determined SMCSO metabolism by 
pure culture of bacteria.
Materials and methods
Bacterial media
Generating a broccoli leachate
Beneforté® broccoli (Marks & Spencers, UK) was steamed 
in a pre-heated domestic steamer for 3 min, snap-frozen and 
stored at – 20 °C. The frozen broccoli was lyophilised using 
a benchtop modulyo freeze drier (Edwards Vacuum) and 
milled using a domestic coffee-bean grinder. Powdered broc-
coli was added to 0.22 μm filtered water (50 mg/ml), vor-
texed and incubated at room temperature for 60 min, prior 
to centrifugation at 5292 ×g, 21 °C, for 10 min. The super-
natant was passed through a Whatman GF/D filter under 
vacuum and the water content was reduced approximately 
tenfold using a BUCHI Rotavapor R-210 rotary evaporator 
set to 60 °C, 72 mbar. The concentrated broccoli leachate 
was filtered under vacuum through a succession of decreas-
ing pore size filters in the following order: Whatman GF/A, 
Whatman GF/B, nitrocellulose membrane 60 μm, 40 μm 
and 0.22 μm. A 600 μl aliquot was removed for high-per-
formance liquid chromatography (HPLC) analysis, with the 
remaining leachate filtered through a Sartolab BT500 0.2 μm 
bottle top filter unit into a sterile bottle and stored at 4 °C.
Preparation of broccoli leachate‑containing media 
and glucose media
Three technical replicates of the broccoli leachate stock solu-
tion were analysed using HPLC to identify the concentration 
of glucoraphanin. Sterility was confirmed by streaking the 
broccoli leachate on brain heart infusion (BHI) agar plates, 
which were incubated anaerobically or aerobically at 37 °C. 
Broccoli leachate was added to Chemostat nutrient media 
(CNM) (peptone water 2 g/l, yeast extract 2 g/l, NaCl 0.1 g/l, 
 K2HPO4 0.04 g/l,  KH2PO4 0.04 g/l,  MgSO4·7H2O 0.01 g/l, 
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 CaCl2·2H2O 0.01 g/l,  NaHCO3 2 g/l, cysteine.HCl 0.5 g/l, 
bile salts 0.5 g/l, Tween 80 2 ml/l, hemin 0.02 g/l and vita-
min  K1 (0.5 v/v in ethanol) 10 μl/l) to make 30 μmole gluc-
oraphanin broccoli leachate-containing (BL) media (relative 
to ~ 47.3 g wet weight broccoli) and the 30 μmole glucose 
media were generated by adding 113.79 mg glucose to 1 l 
CNM. The bottles of prepared media (47.5 ml) were trans-
ferred to an anaerobic cabinet to deoxygenate for 12 h.
Faecal donors
Faecal material was obtained from five participants 
recruited onto the ENGAGE study (ClinicalTrials.gov: 
NCT01927666) who gave written informed consent for their 
stools to be used in these experiments and the resultant data 
to be published in an anonymised form. Details of the fae-
cal donors are displayed in Table 1. The ENGAGE study 
protocol was approved by the Human Research Governance 
Committee at Quadram Institute Bioscience (formally the 
Institute of Food Research) and Hertfordshire Research Eth-
ics Committee (12/EE/0483) and the work described was 
performed in accordance with the Helsinki Declaration of 
1975. All study participants produced a urine sample for 
urinalysis which was screened for protein, blood, leukocytes, 
nitrites, glucose, ketones, bilirubin and urobilinogen via a 
dipstick urine test  (Multistix® SG; Siemens). The exclusion 
criteria included a medical history of gastrointestinal disor-
ders/surgery, long-term medical conditions (e.g. diabetes) or 
those taking medication, such as laxatives, that would have 
affected the study outcome, recent (≤ 1 month) or long-term 
antibiotic use, regular use of over-the-counter medications 
for gastrointestinal-associated conditions, intermittent prebi-
otic &/or probiotic usage, the usage of dietary supplements 
or herbal remedies that would have affected the study out-
come and regular/recent use of colonic irrigation or other 
bowel cleansing techniques.
Culturing human faecal bacteria
Fresh faeces (17 g), voided ~ 2–4 h previously, was placed 
into a stomacher strainer bag (Seward) and deoxygen-
ated PBS was added to obtain a mass of 170 g. The faecal 
matter was homogenised using the Stomacher 400 circula-
tor (Seward, UK) set to 230 rpm, for 45 s. A 100 ml aliquot 
of the homogenised faecal slurry was transferred into an 
anaerobic cabinet set at 37 °C, mixed and 8 ml aliquots were 
stored for 16S rRNA gene analysis. Aliquots (2.5 ml) of 
the faecal slurry were added to the four replicates of each 
deoxygenated media (47.5 ml). The lids of the glass bot-
tles were slightly loosened to allow for gas exchange and 
following a 12 h anaerobic static incubation, aliquots were 
taken for analyses. A 2.5 ml aliquot was transferred from 
each replicate to freshly prepared media (47.5 ml) to start 
the next cycle of culturing. Three 2 ml aliquots, collected 
from each replicate after each 12 h cycle, were centrifuged 
at 9600×g for 5 min and the supernatants were filter-ster-
ilised and stored at − 80 °C for HPLC, LC–MS/MS and 
1H NMR spectroscopy analysis. An 8 ml aliquot, collected 
from each replicate after each 12 h cycle, was centrifuged at 
23,500×g, at 4 °C, for 15 min and the pellets were stored at 
− 80 °C for 16S rRNA gene metataxonomic analysis. The 
sample collection and spiking of fresh media was repeated 
as described above for four 12 h cycles. The metataxonomic 
and 1H NMR results from donor 1 indicated that pH meas-
urements may assist data interpretation, therefore the pH of 
the cultured microbiomes were recorded for donors 2–5. At 
the end of cycle 1 and 4, pH measurements of the cultured 
microbiomes for donors 2–5 were recorded using a Hanna 
HI98103 pH meter (Hanna Instruments, UK). This experi-
mental design was used to culture five independent human 
faecal samples.
Metataxonomic analysis
The DNA of the cultured microbiome was extracted using 
the FastDNA SPIN Kit for Soil (MP Biomedicals, UK) 
with a bead-beating step [36]. DNA quality was assessed 
using 1% agarose gel electrophoresis and quantified with 
a NanoDrop ND-1000 UV/vis spectrophotometer (Nan-
oDrop Technologies, Inc., USA). The samples were sent 
to the Animal Health and Veterinary Laboratories Agency 
(UK), where the V4 and V5 regions of the 16S rRNA genes 
were amplified using the U515F (5′-GTG YCA GCMGCC 
GCG GTA) and U927R (5′-CCC GYC AATTCMTTT RAG T) 
primers. The amplicons were sequenced using 454 pyrose-
quencing, as described by Ellis et al. [37]. Sequencing reads 
were analysed using the Quantitative Insights Into Micro-
bial Ecology (QIIME) 1.8 software and RDP classifier (ver-
sion 2.10) 16S rRNA gene sequence database [38, 39]. All 
sequences were filtered to meet the following criteria: read 
length within 200 and 1000 bp; a maximum of 6 ambiguous 
bases; a minimum average quality score of 25 within a 50 bp 
window; and exact match to primer sequences. The trimmed 
reads were filtered for chimeric sequences using Chimera-
Slayer, bacterial taxonomy assignment with a confidence 
Table 1  Age, gender, body mass index (BMI) and smoking status of 
the donors
Faecal donors Age (years) Gender BMI (kg/m2) Smoker
Donor 1 44 Male 24.1 N
Donor 2 24 Female 23.3 N
Donor 3 52 Female 20.9 N
Donor 4 50 Female 38.4 N
Donor 5 61 Female 20.5 N
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value threshold of 50% was performed with the RDP classi-
fier and trimmed reads clustered into operational taxonomic 
units at 97% identity level.
1H nuclear magnetic resonance spectrometry
Samples (2 ml) were centrifuged at 9600×g at room tem-
perature for 5 min. The supernatants were passed through 
a 0.2 μm syringe filter and stored at − 20 °C. The samples 
were thawed at room temperature, mixed and 600 μl was 
added to 70 μl of 0.4 mM phosphate buffer  (K2HPO4 and 
 NaH2PO4 [pH 7.4]) made up in 100%  D2O, containing 0.1% 
 NaN3 (104 mg) and 2.5 mM sodium 3-(Trimethylsilyl)-pro-
pionate-d4, (TSP) 44.5 mg as a chemical shift reference. The 
samples were mixed and 600 μl was transferred into a 5 mm 
NMR tube for spectral acquisition as previously described 
[40]. Each 1H NMR spectrum was acquired with 64 scans, 
a spectral width of 12,500 Hz, an acquisition time of 2.62 s 
and a relaxation delay of 3 s.
Glucosinolate analysis
Glucosinolates were measured using an adapted method that 
converts glucosinolates to their corresponding desulphoglu-
cosinolates [41]. Briefly, 200 μl of the samples were added 
to 4.8 ml of 70% MeOH (70 °C) and 50 μl of 16 mM sinigrin 
was added to act as an internal standard. Aliquots (3 ml) 
were added to ion exchange columns, washed with 0.22 μm 
filtered water and incubated overnight following the addition 
of purified sulphatase (75 μl). The desulphoglucosinolates 
were eluted with 0.22 μm filtered water and analysed using 
HPLC as described by Saha et al. [25].
Glucosinolate hydrolysis product analysis
Glucosinolate hydrolysis products and their conjugates were 
analysed using a Phenomenex Luna C18(2) (100 × 2 mm id, 
3 μm particle size) column connected to a model 1290 infin-
ity 6490 Triple Quad LC–MS/MS system (Agilent Tech-
nologies) comprised of a degasser, binary pump, cooled 
autosampler, column oven, diode array detector and 6490 
mass spectrometer. The samples were eluted at 0.25 ml/
min with a gradient of increasing acidified ACN: solvent 
A (0.1% ammonium acetate buffer), solvent B (ACN with 
0.1% acetic acid). The gradient increased from 5% acidified 
ACN to 100% over 9.1 min, prior to re-equilibration to 5% 
acidified ACN for 2.9 min. The LC eluent flow was sprayed 
into the mass spectrometer interface without splitting. ITCs 
and their conjugates were monitored by tandem MS using 
multiple reaction monitoring (MRM) with electrospray ioni-
sation source in the positive ion mode. Identification was 
achieved on the basis of retention time and product ions and 
quantification was performed through the use of calibration 
standards.
Bacterial isolation from cultured microbiome
Following the fourth 12 h cycle, the cultures of each media 
were streaked onto BHI agar plates and incubated under 
anaerobic conditions at 37 °C for 48 h. Bacterial isolates 
were transferred to a single well of a 96-well microtitre plate 
containing 300 μl of 30 μmole BL and GL media, respec-
tively, and incubated overnight under anaerobic conditions 
at 37 °C. The contents of each well were transferred to ster-
ile tubes containing 500 μl of 50% glycerol and stored at 
− 80 °C. The isolates were revived by spotting 2 μl onto 
MRS agar plates in duplicate, with each incubated in an 
anaerobic cabinet or a static incubator, both at 37 °C for 
12 h.
Bacterial isolate identification
Colony polymerase chain reaction (PCR) was performed on 
10 colonies. Each colony was transferred to a 50 μl PCR tube 
containing 10 μl of 0.22 μm filtered water and resuspended. 
The resuspended colonies were boiled in a pre-heated 
Hybaid PCR Sprint thermal cycler (Thermo Scientific) set at 
95 °C, for 5 min and used as template DNA. The PCR reac-
tion mixture was generated by adding the following together: 
10 μl 5 × colourless GoTaq reaction buffer (Promega), 0.4 μl 
(25 mM) dNTP mix (Thermo Scientific), 1 μl (20 μM) uni-
versal forward primer (AmpF 5′- GAG AGT TTG ATY CTG 
GCT CAG -3′) [42], 1 μl (20 μM) universal reverse primer 
(AmpR 5′- AAG GAG GTG ATC CAR CCG CA -3′) [42], 
36.35 μl 0.22 μm filtered water, 1 μl template DNA and 
0.25 μl GoTaq DNA polymerase (Promega), to make a final 
volume of 50 μl per reaction mixture. A negative control was 
generated as above with the omission of template DNA and 
increasing the volume of 0.22 μm filtered water to 37.35 μl. 
The thermal cycler was programmed to perform the ampli-
fications as previously described by Nueno-Palop & Narbad 
[43] with minor modifications: one cycle of 95 °C for 2 min 
followed by 25 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C 
for 60 s and one cycle of 72 °C for 5 min. The PCR products 
were resolved by electrophoresis in a 1% (w/v) agarose gel 
and visualised by ethidium bromide staining. PCR amplified 
products were cleaned using QIAquick PCR Purification Kit 
(Qiagen) according to the manufacturer’s instructions.
Two 15 μl aliquots of each cleaned PCR amplicon was 
added to a Eurofins Mix2Seq tube for 16S rRNA gene 
sequencing, with 2 μl of the AmpF primer added to one 
aliquot and 2 μl of the AmpR primer added to the other 
aliquot. The paired samples were assembled to form a sin-
gle contig using SeqMan (DNASTAR, Inc.) and checked 
for errors or mismatches using FinchTV (Geospiza, Inc.). 
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The quality-checked aligned sequences were uploaded to 
the online RDP SeqMatch tool (https ://rdp.cme.msu.edu/
seqma tch/seqma tch_intro .jsp (RDP Data—release11_1; 
Seqmatch—version 3)). The search options enabled were 
type and non-type strains, environmental sequences and iso-
lates, near full length sequences (≥ 1200) and good quality 
sequences. The identification of the bacterial isolates was 
determined on the basis of the highest S_ab score [44].
Potential bacterial reductase screening
Media (CNM or L broth (LB)) was added to 130.95 mg 
purified glucoraphanin extract (Intertek Group plc) to a 
total volume of 2 ml, to generate a 0.15 M glucoraphanin 
stock solution. Five mg powdered SMCSO (Sigma Aldrich) 
had 0.22 μm filtered water added to a total of 5 ml to gen-
erate a 7.4 mM stock solution. Media (955 μl) had 40 μl 
0.15 M glucoraphanin stock solution added to generate a 
6 mM glucoraphanin media and CNM (955 μl) and 40 μl 
7.4 mM SMCSO stock solution were combined to generate 
an SMCSO media (0.3 mM). Each were inoculated with 
5 μl of bacterial glycerol stocks. E. coli DH5α was kindly 
donated by Dr Fatma Cebeci. Control samples were gener-
ated through the addition of 5 μl 0.22 μm filtered water in 
place of 5 μl bacterial glycerol stock. Samples were incu-
bated under static aerobic or anaerobic conditions at 37˚C 
for 24 h or 72 h. Optical density readings were taken at 
600 nm wavelength using a 6715 UV/vis. spectrophotometer 
(Jenway) with control samples used as blanks. Samples were 
centrifuged at 21,100×g for 5 min and the supernatant was 
filter sterilised and stored at − 20 °C for desulphoglucosi-
nolate analysis using HPLC, or SMCSO derivative analysis 
using LC/MS and 1H NMR spectroscopy analysis.
S‑methylcysteine sulphoxide analysis
The cultured samples (100 μl) were mixed with 250 μl 
dansyl chloride reagent (10 mM) and 650 μl borate buffer 
(20 mM; pH 9.2) and incubated at room temperature for 
30 min, prior to centrifugation at 17,000×g for 10 min. The 
supernatants (~ 800 μl) were transferred to autosampler vials 
and LC–MS analysis was performed with a Waters Spher-
isorb ODS2 (4.6 × 250 mm id, 5 μm particle size) column 
connected to an 1100 series Single Quad LC–MS system 
(Agilent Technologies) comprised of a 1200 series degasser, 
binary pump, cooled autosampler, column oven, diode array 
detector and G1956B mass spectrometer. The samples were 
eluted at 0.9 ml/min with a gradient of increasing acidified 
methanol (MeOH): solvent A (50 mM ammonium acetate 
adjusted to pH 5 with 0.1 M acetic acid), solvent B (MeOH 
(1  l) containing 10 mM hydrochloric acid (826 μl 37% 
conc.)). The gradient increased from 30% acidified MeOH 
to 40% over 35 min, then increased from 40 to 75% over 
25 min and after 10 min this re-equilibrated to 30% acidi-
fied MeOH for 5 min. The LC eluent flow was sprayed into 
the mass spectrometer interface without splitting. SMCSO 
isomers were monitored by MS using full scan acquisition 
with electrospray ionisation source in the positive ion mode. 
Identification was achieved on the basis of retention time and 
quantification was performed through the use of calibration 
standards.
Data analysis
Data analysis was performed using GraphPad Prism 5.04 
unless otherwise stated. A probability of p ≤ 0.05 was con-
sidered statistically significant. Statistical analysis of lac-
tate levels was performed using one-way ANOVA followed 
by Bonferroni multiple comparisons tests. Glucosinolate 
data was statistically analysed using paired Student’s t tests 
(two-tailed). The data for the ratios of glucoraphanin and 
glucoerucin between bacterial pure culture samples were 
statistically analysed using two-way ANOVA, whilst the 
analysis of total glucosinolates in pure culture samples vs 
the associated control sample were analysed using Student’s 
t tests (two-tailed).
Results
Effects of broccoli leachate on faecal microbiome 
composition
Faecal samples from five healthy donors were used to inocu-
late both a broccoli leachate-containing (BL) media and a 
glucose (GL) media in five independent experiments. The 
cultures were grown anaerobically at 37 °C and an aliquot 
was taken every 12 h to inoculate the respective fresh media, 
with further aliquots taken for analyses. This was repeated 
with four technical replicates for four 12 h cycles, as pre-
liminary work (not shown) indicated these were sufficient 
parameters to observe stable microbiome modifications. As 
expected, differences in the initial composition of the faecal 
microbiome were observed between the five donors (Fig. 1).
As the experiments progressed, a change in microbiome 
composition occurred and this was largely media-dependent. 
By the fourth 12 h cycle, relatively large increases in the 
proportion of Lactobacillus was observed in the BL media 
to varying degrees, but not the GL media (dark green bar 
in Fig. 1). The average proportion of Lactobacillus present 
in the initial faecal samples was 0.5% (SD ± 0.7%) (Online 
Resource Table 1). The average proportion of the 5 donors 
increased to 10.2% (SD ± 20.6%) after cycle 1 and 42.0% 
(SD ± 31.4%) after cycle 4 in the BL media. As Lactoba-
cillus was only found at detectable levels in the GL media 
at cycle 4 for one donor (donor 3: 0.8% (SD ± 0.1%)), this 
 European Journal of Nutrition
1 3
indicates that the increased growth was due to constituents 
of the broccoli leachate, rather than the experimental con-
ditions or basal media. Interestingly, although proportional 
increases of Lactobacillus in the BL medium was observed 
in the cultured microbiome of donor 4 at cycle 4, the com-
munity was dominated by another lactic acid bacterium, 
Streptococcus (light pink bar in Fig. 1). The starting media 
had a pH of 7.0 ± 0. pH measurements taken at the end of 
cycles 1 and 4 for donors 2–5 indicated the average pH of the 
inoculated BL media was reduced to 4.5 ± 0.2 and 4.9 ± 0.4 
at the end of cycles 1 and 4, respectively (Online Resource 
Table 2). Conversely, the pH of the cultured GL media 
remained stable throughout the experiments; 7.1 ± 0.1 and 
7.0 ± 0.2 at the end of cycles 1 and 4, respectively.
Effects of broccoli leachate on bacterial metabolism
1H NMR spectroscopy quantification of fermented samples 
showed relatively high levels of lactate (23.5–36.3 mM) for 
four of the five microbiomes (donors 2–5), in the BL media 
after cycle 4. However, significantly lower levels of lactate 
were detected in the BL media at cycle 4 for the cultured 
microbiome of donor 1 (Fig. 2). The decrease in lactate 
concentration between cycles 1 and 4 for donor 1 may have 
been due to increased lactate utilisation by the microbiome. 
Although lactate was detected in the GL media after cycle 1, 
when cultured with three of the faecal microbiomes (donors 
3–5), it was only present in low amounts (0.07–0.84 mM) 
(Online Resource table 3). Lactate was only detected in 
the GL media after cycle 4 when cultured with the faecal 
microbiome of donor 5 (0.17 mM). 1H NMR spectroscopy 
was used to identify the concentrations of SCFAs (acetate, 
butyrate, formate, propionate and valerate) in the cultured 
BL and GL media (Table 2). The inoculated microbiome of 
donor 1 produced a variety of SCFAs, as well as the highest 
total yield of SCFAs (60.3 mM). Valerate was only detected 
in the samples from donors 1 and 3, whilst neither butyrate 
nor propionate were observed in the cultured samples from 
donors 2 and 5. The relatively high concentration of valer-
ate in the samples inoculated with the faecal bacteria of 
donor 1 may be linked to the detection of Megasphaera, a 
known valerate producer, in the cultured bacterial commu-
nity. The lowest total yield of SCFAs was observed in the 
sample derived from donor 4 (6.5 mM) and this was largely 
composed of acetate and formate. On average, across all 
five faecal microbiomes tested, there was a 2.2-fold increase 
in total yield of SCFAs in the BL vessels compared to the 
GL vessels. The increased levels of the SCFAs found in the 
BL fermentation likely reflects the availability of nutrients 
derived from the broccoli leachate and will link to the meta-
bolic capabilities of each microbiome.
Reduction of glucosinolates by faecal microbiome
Fermentation samples were also analysed to deter-
mine whether these microbial communities were able to 
Fig. 1  The proportions of Lactobacillus or Streptococcus increase 
after culturing faecal microbiomes in a media containing a broccoli 
leachate. Five human faecal slurries were cultured independently in 
a broccoli leachate (BL) containing media and a glucose (GL) media. 
The bar chart displays the proportion of OTUs per cultured faecal 
microbiome of each donor after the first (1) and last 12 h cycle (4). 
The key reads from top left to bottom right and consists of genera 
with a relative abundance ≥ 1% in at least one sample. Asterisk repre-
sents OTU reported at a higher taxonomic level
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metabolise the glucosinolates derived from the broccoli. 
HPLC analysis indicated that, of five independent experi-
ments, four cultured faecal bacterial communities (donors 1, 
3, 4 and 5) exhibited the ability, to varying degrees, to bio-
transform glucoraphanin and glucoiberin, converting them 
to their reduced analogues glucoerucin and glucoiberverin, 
respectively. Figure 3 shows the level of glucosinolate con-
version performed by the faecal microbiome of donor 5. 
However, the bacterial community of donor 2 did not seem 
to have the ability to reduce the glucosinolates, but as with 
all the faecal microbiomes tested, a decrease in glucorapha-
nin and glucoiberin levels were observed across each 12 h 
cycle (Online Resource table 4).
In order to determine the fate of the missing glucorapha-
nin at cycle 4, LC–MS/MS was used to identify known 
glucoraphanin breakdown products. Low levels of the ITC 
sulphoraphane (SF) and SF nitrile were present in the start-
ing media and the levels of both decreased within each 12 h 
cycle during all five experiments (Online Resource Fig. 1). 
However, combining the HPLC and LC–MS/MS data of glu-
coraphanin, glucoerucin and their related hydrolysis prod-
ucts over each 12 h culturing period, did not account for the 
total amount of glucoraphanin and associated breakdown 
products present in the starting media.
Ten bacterial isolates, obtained from BL media cultured 
microbiomes, were selected at random and screened for 
their ability to convert glucoraphanin to glucoerucin in 
pure cultures. Four isolates identified as belonging to the 
genus Escherichia were able to substantially reduce glu-
coraphanin to glucoerucin (77.7–89%) (Online Resource 
table 5). The remaining six isolates, that did not exhibit the 
ability to reduce glucoraphanin, included bacteria from the 
order Lactobacillales: four L. fermentum isolates and two 
Enterococcus species (E. faecium and E. durans). One E. 
coli (strain 1B04) with the ability to reduce glucoraphanin 
to glucoerucin was chosen for further study. This isolate 
was cultured separately in CNM and LB supplemented 
with purified glucoraphanin to a concentration of ~ 6 mM 
under aerobic and anaerobic conditions to investigate 
whether differences in atmosphere or media would affect 
bacterial reductase activity. No significant difference in 
reductase activity was observed between aerobic or anaer-
obic conditions within each media type, but the conversion 
of glucoraphanin to glucoerucin was lower in LB media, 
compared to CNM media (Fig. 4). However, when the cul-
turing period was extended to 72 h under anaerobic condi-
tions (aerobic conditions not tested), a similar level of glu-
coraphanin conversion was observed for both media types, 
although the optical density measurements at 72 h were 
similar to those recorded at 24 h for each cultured media; 
CNM—0.798, LB—1.400 (Online Resource Fig. 2).
Further work with E. coli 1B04 indicated that this 
bacterial isolate was unable to convert glucoerucin to 
glucoraphanin via an oxidation reaction, or hydrolyse 
glucoerucin (Online Resource Fig.  3). We also tested 
the laboratory strain E. coli DH5α, which was devel-
oped as a laboratory cloning strain via mutagenesis of 
an isolate obtained from a patient in 1920 [45]. E. coli 
DH5α was cultured in CNM containing glucoraphanin to 
assess whether the ability to reduce glucoraphanin was 
specifically associated with E. coli adapted to the human 
gut, as DH5α is considered to not have a natural habi-
tat. Although E. coli DH5α grew relatively poorly in this 
media  (OD600 = 0.286), this strain was still able to convert 
glucoraphanin to glucoerucin (Fig. 5). This suggests that 
the ability to reduce sulphoxide groups is not restricted to 
gut-adapted E. coli and may be a general metabolic pro-
cess rather than a glucosinolate-specific process.
Fig. 2  Lactate accumulated in 
a broccoli leachate-containing 
media when cultured with 
human faecal microbiomes. 
Lactate levels in the pre-
inoculated BL media and 
cultured BL media after cycles 
1 and 4 for the microbiomes 
obtained from donors 1–5. Data 
shown = mean ± SD of four 
technical replicates. **p ≤ 0.01, 
***p ≤ 0.001 Cycle 1 vs Cycle 4
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Bacterial reduction of S‑methylcysteine sulphoxide 
(SMCSO)
To investigate whether the observed putative reductase 
activity was glucoraphanin-specific or extendable to other 
compounds, E. coli 1B04 was cultured in a media contain-
ing SMCSO, another broccoli-derived compound containing 
a sulphoxide moiety. Levels of SMCSO decreased signifi-
cantly over a period of 24 h in the presence of E. coli 1B04 
(Fig. 6). SMCSO levels remained stable in the control sam-
ples devoid of bacteria, reflecting the importance of E. coli 
1B04 for the metabolic breakdown of SMCSO. Analysis 
using 1H NMR spectroscopy identified S-methylcysteine, the 
reduced analogue of SMCSO, which was only detected in 
the SMCSO-containing CNM media incubated with E. coli 
1B04 (Fig. 7).
Discussion
The current study demonstrated that culturing human fae-
cal microbiomes in the presence of broccoli leachate (BL) 
resulted in an alteration of the composition of the in vitro 
faecal microbiome. After the fourth cycle of culturing the 
microbiome in BL, the microbiomes of 4 of the 5 donors 
were dominated by Lactobacillus, whereas this modifica-
tion was not observed when the microbiome was cultured in 
media containing glucose. In a previous study by Filannino 
et al. [46], the metabolism of phenolic compounds by Lac-
tobacillus sp. was investigated using a broccoli puree. All 
strains tested exhibited good growth and it was found that 
two strains of Lactobacillus (L. fermentum FUA3165 and 
L. reuteri FUA3168) were able to reduce quinic acid, which 
was postulated to give these organisms an energetic advan-
tage through  NAD+ regeneration [46]. In vitro and in vivo 
studies have indicated that the bacterial metabolism of die-
tary components, such as fibres, polyphenols and glycated 
proteins, may have the potential to modify gut microbiomes 
via an increase of beneficial intestinal lactobacilli [47–50]. 
In this study, the increase in lactobacilli is likely largely due 
to the presence of sugars, however soluble fibre may have 
also played a role but fibre analyses were not carried out so 
this cannot be confirmed.
In one experiment, with an independent donor, where 
a bloom of Lactobacillus was not observed, Streptococ-
cus was present at the largest proportion. Lactobacillus 
and Streptococcus are from the order Lactobacillales and 
are considered core members of the LAB. This group of 
Gram-positive bacteria are found in the small intestine and 
colon, where they metabolise dietary carbohydrates. Broc-
coli is rich in galacturonic acid, glucose, galactose and ara-
binose, with lesser amounts of mannose, xylose, rhamnose 
and fucose also present [51]. This source of carbohydrates Ta
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may have provided Lactobacillus and Streptococcus with a 
competitive advantage over other members of the in vitro 
microbiome. The observed proportional increase in LAB 
was correlated with a decrease in the pH of the fermentation 
media from 7.0 to 4.9. However, it is important to note that 
the bacterial metabolism of simpler carbohydrates, such as 
sugars, largely takes place in the small intestine and the pH 
decreases observed in these experiments do not reflect the 
pH of the human colon. Therefore, although the microbiome 
results are of interest in an in vitro setting, we would not 
expect to observe similar compositional changes in vivo. 1H 
NMR spectroscopy of the culture media indicate that the 
observed decrease in pH was associated with the production 
of lactic acid by the LAB. However, in one fermentation 
with the microbiome of donor 1 the levels of lactate did 
Fig. 3  Conversion of glucosinolates to their reduced analogues 
when cultured with a human faecal microbiome. The conversion 
of glucoraphanin to glucoerucin and glucoiberin to glucoiberverin 
by the faecal microbiome of donor 5, which is representative of the 
trend seen for the microbiomes of donors 1, 3 and 4. No conversion 
was observed for the microbiome of donor 2. GR; Glucoraphanin: 
G-ERN; Glucoerucin: GI; Glucoiberin: GIV; Glucoiberverin. Data 
shown = mean ± SD of four technical replicates. *p ≤ 0.05, **p ≤ 0.01, 
***p ≤ 0.001 zero hr vs 12 h
Fig. 4  The ratio of glucoraphanin to glucoerucin differs between the 
CNM and LB media when cultured with Escherichia coli 1B04, irre-
spective of oxygen levels. E. coli 1B04 was cultured in CNM and LB 
media containing purified glucoraphanin extract at ~ 6 mM for 24 h at 
37 °C, under both anaerobic and aerobic conditions. GR, glucorapha-
nin; G-ERN, glucoerucin; CNM, chemostat nutrient media; LB , L 
broth. Data shown = mean ± SD of two technical replicates. Ratio of 
glucoraphanin and glucoerucin between samples; a vs b p ≤ 0.001. 
Total glucosinolates in cultured samples vs control sample; *p ≤ 0.05, 
**p ≤ 0.01
Fig. 5  The laboratory strain, Escherichia coli DH5α, has the abil-
ity to convert glucoraphanin to glucoerucin. E. coli DH5α was cul-
tured in CNM containing ~ 7  mM purified glucoraphanin extract 
for 24  h at 37  °C under anaerobic conditions. GR = Glucorapha-
nin; G-ERN = Glucoerucin; CNM = Chemostat nutrient media; 
DH5α = Escherichia coli DH5α. Data shown = mean ± SD of three 
technical replicates
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not increase. Lactate is the major metabolic end product of 
carbohydrate fermentation by LAB and can be subsequently 
utilised by other members of the gut microbiome to gener-
ate bacterial metabolites, such as SCFAs. Acetate, butyrate, 
formate, propionate and valerate were all detected during the 
fermentation of both the broccoli leachate or glucose, but 
there was on average, a 2.2-fold increase in the total yield 
of these SCFAs in the presence of BL. We hypothesised that 
the microbiomes cultured in the BL media utilised available 
lactate for metabolic processes, leading to a greater yield of 
SCFAs.
Acetate was the primary SCFA produced from all cul-
tured microbiomes, as has been observed in the human colon 
and faeces [52]. Acetate or butyrate can be produced through 
the bacterial utilisation of pyruvate, which can be formed 
through the oxidation of lactate [53], or lactate can be used 
directly in the acrylate pathway to generate propionate [54]. 
Relatively high concentrations of propionate were only 
detected in the fermentations with BL (Table 2). This may 
indicate that lactate was being produced by the microbiome, 
but was partly channelled into the production of propionate. 
The microbiome of donor 1 contained a relatively high pro-
portion of the genus Megasphaera, which was not detected 
in the other samples. Megasphaera elsdenii is an intestinal 
Fig. 6  Levels of S-methylcysteine sulphoxide decrease when incu-
bated with E. coli 1B04. E. coli 1B04 was cultured in CNM contain-
ing 0.3 mM SMCSO for 24 h at 37 °C, under anaerobic conditions. 
SMCSO = S-methylcysteine sulphoxide; CNM = Chemostat nutri-
ent media; 1B04 = Escherichia coli 1B04; T0 = prior to inoculation; 
T24 = 24 h post-inoculation. Data shown = mean ± SD of three techni-
cal replicates
Fig. 7  1H NMR spectra of medium supplemented with S-methyl-
cysteine sulphoxide with and without E. coli 1B04. Substrates, such 
as SMSCO, aspartate, asparagine, cystine, proline, trehalose and 
some nucleosides (not shown) were consumed. Products, such as 
methylcysteine, cystathionine (another cysteine derivate), methionine, 
choline, dihydroxyacetone, dihydrouracil, succinate, fumarate, etha-
nol, acetate and formate (not shown) appeared
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bacterium that converts lactate to propionate via the acrylate 
pathway [55]. When glucose and lactate are both available, 
M. elsdenii produces increasing amounts of butyrate and 
valerate, with a concomitant decrease in the production of 
propionate [56]. When glucose is depleted, lactate is metab-
olised to produce propionate. The presence of Megasphaera 
in the BL media cultured with the faecal microbiome of 
donor 1 may be at least partly responsible for the relatively 
high concentration of both propionate and valerate, as well 
as contributing to butyrate production. SCFAs are mainly 
produced by the bacterial fermentation of non-digestible 
carbohydrates that pass through the small intestine to the 
colon. However, under the in vitro conditions detailed here, 
the bacteria would be able to use the available sugars to 
produce SCFAs. These results would have been strengthened 
by analysing the soluble fibre content of the BL media and 
as such it is difficult to relate these results to in vivo SCFA 
production following the consumption of broccoli.
When human faecal bacteria were cultured in a BL media, 
decreases in the levels of glucoraphanin and glucoiberin 
were recorded for each experiment, with a concomitant 
appearance of the reduced analogues glucoerucin and glu-
coiberverin, respectively, observed in four of the five experi-
ments. This reduction was microbiome dependent and the 
reduction of glucosinolates by a human faecal microbiome 
[25] and bacteria isolated from human faecal material [23] 
has previously been reported. This suggests that the micro-
biome of donor 2, in which glucosinolate reduction was not 
observed, may have lacked the bacteria able to perform the 
reduction reaction.
We also examined the ability of individual gut bacteria to 
reduce glucoraphanin.
We identified four strains with this activity, all of which 
belong to the genus Escherichia. It is interesting to note that 
the BL fermentation with the faecal microbiome of donor 2 
did not show a high abundance of Escherichia and the con-
version of glucoraphanin to glucoerucin was not observed. 
Whilst the anaerobic environment did not play a role in the 
reduction of glucoraphanin by E. coli 1B04, the type of cul-
ture media used affected the rate of glucoraphanin reduction, 
with lower levels of glucoerucin detected in LB, compared 
to CNM, over 24 h. This corresponded to increased growth 
of E. coli 1B04 in LB, compared to CNM. Differences in 
potential co-factors between the media may also impact on 
this reduction activity.
Growth of E. coli 1B04 in CNM media containing glu-
coerucin indicated that glucoerucin was not metabolised. 
Research by Simala–Grant and Weiner showed that the 
anaerobic growth of E. coli, on various sulphoxides, was 
only supported following the reduction of these com-
pounds by DMSO reductase [57]. This enabled the sulph-
oxides to act as electron acceptors, which can be used by 
E. coli to drive ATP synthesis through anaerobic respira-
tion. Therefore, the difference in the rate of glucoraphanin 
reduction observed in this study may reflect the presence 
of preferred electron acceptors in the LB media, which are 
modified by other enzymes. E. coli is known to express 
a wide range of reductases, such as terminal reductases 
used in anaerobic respiration [58], methionine sulphoxide 
reductases that counteract damage that can be caused by 
reactive oxygen species [59] and ribonucleotide reduc-
tases, which are involved in the synthesis of DNA [60].
The laboratory strain E. coli DH5α was also able to 
reduce glucoraphanin, suggesting that the enzymes respon-
sible for the glucosinolate reduction may be broad-range 
non-specific enzymes. It is not unreasonable to suggest 
that sulphoxide reduction in anaerobic environments 
may provide electron acceptors for anaerobic respiration, 
whilst similar reductase activity in an aerobic environ-
ment may serve to protect E. coli from oxidative damage. 
To test the hypothesis that the observed glucoraphanin 
reduction was not glucosinolate-specific, E. coli 1B04 
was cultured in CNM containing S-methylcysteine sulph-
oxide (SMCSO). A significant decrease in the levels of 
SMCSO was observed and 1H NMR analysis indicated that 
a large proportion of SMCSO was putatively converted 
to the reduced analogue, S-methylcysteine. Although glu-
coraphanin and SMCSO may have been reduced by the 
actions of different enzymes, it is plausible that the activ-
ity of a single enzyme with broad substrate specificity is 
responsible.
This study reinforces the point that the composition 
of bacterial communities and the profile of their metabo-
lites can be directly affected by diet in general. However, 
the bioconversion of individual phytochemicals within 
the diet, such as glucosinolates, may confer additional 
health benefits to the host. We believe that this is the first 
study that shows the reduction of the dietary compound 
S-methylcysteine sulphoxide by bacteria isolated from 
human faeces.
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